<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Three patients with surgically inaccessible giant carotid <z:hpo ids='HP_0002617'>aneurysms</z:hpo>/pseudoaneurysms and one patient with carotid cavernous <z:mpath ids='MPATH_70'>fistula</z:mpath> had endovascular occlusion with detachable <z:chebi fb="144" ids="48140">silicone</z:chebi> balloons filled with Cholografin </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> was performed before the procedures in three cases and again 18 hr to 44 days after embolization in <z:hpo ids='HP_0000001'>all</z:hpo> four cases </plain></SENT>
<SENT sid="2" pm="."><plain>The age-related changes of arterial <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e>, as well as the optimal timing and value of different pulse sequences in the noninvasive follow-up, were evaluated </plain></SENT>
<SENT sid="3" pm="."><plain>Arterial <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> have some characteristics in common with intracerebral <z:mp ids='MP_0008817'>hematomas</z:mp>, being isointense on T1-weighted spin-echo images during <z:hpo ids='HP_0011009'>acute</z:hpo> phase and subsequently acquiring hyperintense signals on both T1- and T2-weighted spin-echo images during the <z:hpo ids='HP_0011011'>subacute</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> phases </plain></SENT>
<SENT sid="4" pm="."><plain>Additional observations are that (1) hyperacute (less than 24 hr old) <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> is hyperintense on T2-weighted spin-echo sequences; (2) hemosiderin is less conspicuous in <z:hpo ids='HP_0011010'>chronic</z:hpo> intraluminal <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> than in intracerebral <z:mp ids='MP_0008817'>hematomas</z:mp> of comparable size; and (3) <z:mp ids='MP_0005048'>thrombosis</z:mp> is initiated at a site remote from the apex of the <z:hpo ids='HP_0002617'>aneurysm</z:hpo> and then progresses centripetally </plain></SENT>
<SENT sid="5" pm="."><plain>The Cholografin-filled balloon is hypointense to gray matter on T1-weighted spin-echo images and isointense to both hyperacute and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> on T2-weighted spin-echo images </plain></SENT>
<SENT sid="6" pm="."><plain>The optimal timing and sequence for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> follow-up of a thrombosed <z:hpo ids='HP_0002617'>aneurysm</z:hpo> with conventional spin-echo technique is beyond 7 days on T1-weighted spin-echo images </plain></SENT>
<SENT sid="7" pm="."><plain>The in vivo appearance of Cholografin-filled <z:chebi fb="144" ids="48140">silicone</z:chebi> balloons does not change appreciably on T1- and T2-weighted spin-echo sequences up to 6 weeks if filled according to the manufacturer's specification </plain></SENT>
</text></document>